You can buy or sell JAZZ and other stocks, options, ETFs, and crypto commission-free!
Jazz Pharmaceuticals Plc operates as a specialty biopharmaceutical company, which focuses on the identification, development and commercialization of pharmaceutical products in the areas of narcolepsy, oncology, pain and psychiatry. Its product portfolio includes: XYREM, ERWINAZETM, PRIALT, intrathecal infusion, FAZACLO and LUVOX CR. Read More The company was founded by Bruce C. Cozadd in March 2003 and is headquartered in Dublin, Ireland.
52 Week High
52 Week Low
— per share
Expected May 5, After Hours